On IDSA’s & HIVMA’s Science Speaks: Ticks may harbor a wider mix of pathogens than once thought, and co-infections remain vital to consider in the care of patients with suspected or proven tick-borne infections, writes Melvin Sanicas, MD, MSc, MScID, MBA. bit.ly/4u00zLJ
On IDSA’s & HIVMA’s Science Speaks blog: Geeta Sood, MD, ScM, and Julie Caffrey, DO, MS, offer key takeaways drawing from the literature and experiences caring for burn patients in a regional high-volume burn center. https://bit.ly/4cRaPPB
New #LetsTalkID out now! @paulsaxmd.bsky.social and guest Rebeca Plank, MD, MPH, share their picks for infectious diseases “love/hates," discussing the tools, tests and clinical strategies that inspire both enthusiasm and hesitation in everyday ID practice.
Transcript: bit.ly/48ECIJ8
IDSA has joined more than 130 medical, nursing, public health and patient advocacy organizations in expressing concern about the revised charter for the Advisory Committee on Immunization Practices (ACIP). https://bit.ly/4cxwPyu
ID fellows: Join us for the next virtual Fellows Case Conference on Tuesday, April 28 at 3pm ET.
Explore a unique ID case alongside presenters Kelly Hallowell, MD, and Sophia Lewis, MD, PhD, and discussant Luis Parra-Rodriguez, MD.
Register: https://bit.ly/4sC1zUY
Thank you @baldwin.senate.gov & Sen. Susan Collins for introducing S. 4283 to reauthorize the Public Health and Bio-Preparedness Workforce Loan Repayment Programs to strengthen the ID, HIV & public health workforce.
IDSA & @hivma.bsky.social call on Congress to swiftly reauthorize: bit.ly/4vyUlnz
Outpatient antibiotic stewardship programs (ASP) are recommended by the CDC and Joint Commission.
In CID, authors analyzed the impact of annual, focused syndrome-specific ASP interventions on trends in long-duration antibiotic prescribing. https://bit.ly/3Oik1nK
#STIweek is here! Learn how these three steps can prevent #STIs: https://bit.ly/3OI5amf #TalkTestTreat
DYK? IDSA's Leadership Institute has TWO pathways: Rising Leaders for early-career ID professionals (online) and Community of Leaders for mid/senior-career pros (hybrid).
Both programs run once a year.
Get notified when applications open: https://bit.ly/4tNRR3O
IDSA is championing evidence-based policy and investments in ID research, public health and care. Your donations to the IDSA Foundation fuel the experts, education and advocacy needed to protect access to lifesaving vaccines and more.
Donate today: https://bit.ly/4cxqZhT
On IDSA’s & HIVMA’s Science Speaks blog: A study in JAMA Network Open investigated a mobile telemedicine-based intervention for hepatitis C virus infection. Read IDSA’s Journal Club review by Erica Kaufman West, MD, FIDSA. https://bit.ly/4cBvxDW
The updated charter of CDC’s Advisory Committee on Immunization Practices is another alarming action by Sec. Kennedy that will further dismantle U.S. vaccine infrastructure, spread vaccine misinformation, and lead to reduced vaccine uptake.
Our statement: bit.ly/4slGmP7
Maintaining robust support for research overhead costs — as IDSA has advocated for — is critical to sustaining lifesaving biomedical research. https://bit.ly/4cuNYdr
ICYMI: A recording of our joint webinar with ESCMID, "AMR Diagnostics: Are We Really Missing the Right Assays?" feat. speakers Adrian Egli, MD, PhD, and Alexandra Yamshchikov, MD, is now available on the IDSA Academy: https://bit.ly/4dvhosX
Infectious diseases experts call on Secretary Kennedy to maintain the scientific integrity of the Centers for Disease Control and Prevention’s Advisory Committee on Immunizations Practices charter as he undertakes his review.
Our statement: https://bit.ly/3PX8BWW
The nontuberculous mycobacteria (NTM) isolated from gastric aspirate have demonstrated >85% strain concordance with those from the sputum.
In OFID, authors evaluate whether mycobacterial strains from gastric aspirate and sputum cultures were identical. https://bit.ly/4sJNHco
The proposed $22M increase for CDC’s Antibiotic Resistance Solutions Initiative in the president’s FY27 budget request is a critical step, but these investments rely on public health and research infrastructure marked for severe cuts.
Our statement: https://bit.ly/4sf5MxP
Junior infectious diseases faculty: Get hands-on experience in medical journal editing. The IDSA Journals Editorial Mentoring Program offers mentorship and training in the day-to-day work of a medical journal editor.
Learn more and apply by 5/15: https://bit.ly/3BIR624
A key insight from infectious diseases physician Tim Menza, MD, PhD, led to the diagnosis of rare pulmonary tularemia in a challenging case. https://bit.ly/4sPvCcQ
*The Washington Post subscription required.
On IDSA’s & HIVMA’s Science Speaks blog: Telemedicine offers an effective and efficient, evidence-based solution to bridge the gap between workforce shortages and clinical need. But there are challenges to overcome, writes Linda Nabha, MD. https://bit.ly/4mbLFzk
IDSA’s and HIVMA’s Science Speaks blog reminds readers that infectious diseases don’t observe national borders, and effective, evidence-based responses protect us all.
Subscribe to Science Speaks for on-the-ground experiences of members, staff and other ID experts: https://bit.ly/3OlHN22
🚨 LAST CALL: Know an IDSA member making a difference locally and around the world? 🌎 Nominate them for a 2026 IDSA & HIVMA Society Award now through next Tuesday, April 7: bit.ly/45zhH0Z
Help celebrate the colleagues whose work advances infectious diseases research, care, education, and advocacy.
Expand your ID expertise with the IDSA Academy, your centralized hub for infectious diseases education, for clinicians, researchers and ID professionals at every stage.
Stay current, sharpen your skills and explore new content: https://academy.idsociety.org/
In CID, authors investigate the effects of changes in implementation of 3 major methicillin-resistant Staphylococcus aureus (MRSA) prevention practices on MRSA infection rates during the COVID-19 pandemic to inform future infection control policies in healthcare environments. https://bit.ly/4bNC78E
Thank you @trahan.house.gov for leading the FY27 letter supporting funding for the Bio-Preparedness Workforce Pilot Program.
Investment in the ID/HIV workforce helps ensure communities are prepared to respond to infectious disease threats. #ValueofID
📃 bit.ly/41BjFLS
On IDSA’s & HIVMA’s Science Speaks blog: A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia across a large integrated health system. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA: https://bit.ly/3NOpG4M
🚨LAST CALL: Apply by TOMORROW, March 31 to join IDSA’s Journals Reader Panel! Readers of CID, OFID and JID can give feedback and engage directly with our editors, learn about new journal initiatives and more: https://bit.ly/406h4ZG
Thank you @crow.house.gov for leading the FY27 letter supporting funding for the Bio-Preparedness Workforce Pilot Program.
Loan repayment helps strengthen the ID and HIV workforce and improves preparedness for infectious disease threats. #ValueofID
📃 bit.ly/41BjFLS
In 2025, the IDSA Foundation:
🎁 Raised $254K from individual donors
🤝 Raised $102K in matched donations
🌱 Supported 72 early-career professionals with grants
💵 Awarded $1.5M in corporate partnerships
Learn about our impact in 2025: https://bit.ly/4bWmKuT
OFID recognizes Maria Mendoza, MD, for being one of the journal’s top reviewers. Dr. Mendoza is an ID physician and assistant professor at the University of Utah, specializing in transplant ID.
Learn how to receive recognition and rewards as a peer reviewer: https://bit.ly/4aoKJ6S
